CytomX Therapeutics, Inc. Interest Expense
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2018-03-07
- CytomX Therapeutics, Inc. interest expense for the quarter ending 2017-03-31 was $206.00K, a 41.64% decline year-over-year.
- CytomX Therapeutics, Inc. interest expense for the quarter ending 2016-12-31 was $389.00K, a 3.46% increase year-over-year.
- CytomX Therapeutics, Inc. interest expense for the quarter ending 2016-09-30 was $482.00K, a 32.87% decline year-over-year.
- CytomX Therapeutics, Inc. interest expense for the quarter ending 2016-06-30 was $465.00K, a 13.97% increase year-over-year.
- CytomX Therapeutics, Inc. interest expense for fiscal 2016 was $1.69M, a 2.48% decline from fiscal 2015.
- CytomX Therapeutics, Inc. interest expense for fiscal 2015 was $1.73M, a 255.65% increase from fiscal 2014.
- CytomX Therapeutics, Inc. interest expense for fiscal 2014 was $487.00K, a 91.73% increase from fiscal 2013.
- CytomX Therapeutics, Inc. interest expense for fiscal 2013 was $254.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2017-03-31 | $206.00K 10-Q · filed 2017-05-05 | $595.00K derived: sum of 2 quarters · filed 2017-05-05 | $1.08M derived: sum of 3 quarters · filed 2017-05-05 | $1.54M derived: sum of 4 quarters · filed 2017-05-05 |
| 2016-12-31 | $389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $871.00K derived: sum of 2 quarters · filed 2017-03-02 | $1.34M derived: sum of 3 quarters · filed 2017-03-02 | $1.69M 10-K · filed 2017-03-02 |
| 2016-09-30 | $482.00K 10-Q · filed 2016-11-03 | $947.00K derived: sum of 2 quarters · filed 2016-11-03 | $1.30M 10-Q · filed 2016-11-03 | $1.68M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $465.00K 10-Q · filed 2016-08-03 | $818.00K 10-Q · filed 2016-08-03 | $1.19M derived: sum of 3 quarters · filed 2018-03-07 | $1.91M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $353.00K 10-Q · filed 2017-05-05 | $729.00K derived: sum of 2 quarters · filed 2018-03-07 | $1.45M derived: sum of 3 quarters · filed 2018-03-07 | $1.85M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $1.09M derived: sum of 2 quarters · filed 2018-03-07 | $1.50M derived: sum of 3 quarters · filed 2018-03-07 | $1.73M 10-K · filed 2018-03-07 |
| 2015-09-30 | $718.00K 10-Q · filed 2016-11-03 | $1.13M derived: sum of 2 quarters · filed 2016-11-03 | $1.36M 10-Q · filed 2016-11-03 | $1.47M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $408.00K 10-Q · filed 2016-08-03 | $638.00K 10-Q · filed 2016-08-03 | $747.00K derived: sum of 3 quarters · filed 2017-03-02 | $864.00K derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-03-31 | $230.00K 10-Q · filed 2016-05-06 | $339.00K derived: sum of 2 quarters · filed 2017-03-02 | $456.00K derived: sum of 3 quarters · filed 2017-03-02 | |
| 2014-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $226.00K derived: sum of 2 quarters · filed 2017-03-02 | $487.00K 10-K · filed 2017-03-02 | |
| 2014-09-30 | $117.00K 10-Q · filed 2015-11-23 | $378.00K 10-Q · filed 2015-11-23 | ||
| 2013-12-31 | $254.00K 10-K · filed 2016-03-07 |